Cart
sales@molnova.com
BHQ
CAS No. 88-58-4
BHQ( —— )
Catalog No. M20884 CAS No. 88-58-4
BHQ is an effective and selective endoplasmic reticulum Ca2+-ATPase inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 37 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBHQ
-
NoteResearch use only, not for human use.
-
Brief DescriptionBHQ is an effective and selective endoplasmic reticulum Ca2+-ATPase inhibitor.
-
DescriptionBHQ is an effective and selective endoplasmic reticulum Ca2+-ATPase inhibitor.
-
In VitroDTBHQ influences arachidonic acid (AA) metabolism in biologically relevant concentrations in vitro.
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetATPase
-
RecptorCa2+-ATPase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number88-58-4
-
Formula Weight222.32
-
Molecular FormulaC14H22O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:10mg/mL(44.98mM)
-
SMILESCC(C)(C)c1cc(O)c(C(C)(C)C)cc1O
-
Chemical Name25-Di-tert-butylhydroquinone
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Fusi F Saponara S Gagov H et al. 25-Di-t-butyl-14-benzohydroquinone (BHQ) inhibits vascular L-type Ca2+channel?via?superoxide anion generation?[J]. British Journal of Pharmacology 2001 133(7):988-996.
molnova catalog
related products
-
ATP synthase inhibit...
ATP synthase inhibitor 1 is an inhibitor of the c subunit of the F1/FO-ATP synthase complex. It inhibits mitochondrial permeability transition pore (mPTP) opening and does not affect ATP levels.
-
NDI-091143
NDI-091143 is a potent and high-affinity human ATP-citrate lyase (ACLY) inhibitor with an IC50 of 2.1 nM (ADP-Glo assay)indirectly disrupting citrate binding via an unexpected mechanism of inhibition.
-
(-)-Hydroxycitric ac...
(-)-Hydroxycitric acid (Garcinia acid) is the principal acid of fruit rinds of Garcinia cambogia. It is a potent and competitive inhibitor of ATP citrate lyase. (-)-Hydroxycitric acid suppresses fatty acid synthesis, food intake, lipogenesis, and induced weight loss.
